Ignite Creation Date:
2025-12-26 @ 11:49 AM
Ignite Modification Date:
2025-12-26 @ 11:49 AM
Study NCT ID:
NCT01046916
Status:
COMPLETED
Last Update Posted:
2016-04-04
First Post:
2010-01-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of TAK-700 in Patients With Nonmetastatic Castration-resistant Prostate Cancer and a Rising Prostate-specific Antigen
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-05
Start Date Type:
None
Primary Completion Date:
2013-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03
Completion Date Type:
ACTUAL
First Submit Date:
2010-01-11
First Submit QC Date:
None
Study First Post Date:
2010-01-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-04-04
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-03-04
Last Update Post Date:
2016-04-04
Last Update Post Date Type:
ESTIMATED